Bartter syndrome natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) |
||
| Line 17: | Line 17: | ||
Kidney failure is a possible complication. | Kidney failure is a possible complication. | ||
*Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis.<ref name="pmid18695706">{{cite journal| author=Seyberth HW| title=An improved terminology and classification of Bartter-like syndromes. | journal=Nat Clin Pract Nephrol | year= 2008 | volume= 4 | issue= 10 | pages= 560-7 | pmid=18695706 | doi=10.1038/ncpneph0912 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18695706 }} </ref> | *Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis.<ref name="pmid18695706">{{cite journal| author=Seyberth HW| title=An improved terminology and classification of Bartter-like syndromes. | journal=Nat Clin Pract Nephrol | year= 2008 | volume= 4 | issue= 10 | pages= 560-7 | pmid=18695706 | doi=10.1038/ncpneph0912 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18695706 }} </ref> | ||
*Gallstones might represent a new complication of antenatal Bartter syndrome.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> | *Gallstones might represent a new complication of antenatal Bartter syndrome.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> Gallstone formation might result from an altered function of either the sodium–potassium–chloride cotransporter or the channel ROMK within the hepatobiliary system.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> | ||
*[[Hypokalemia]] in [[Bartter syndrome]] can be exacerbated by [[electrolytes]] and fluid losses. [[Diarrhea]], [[vomiting]], [[alcohol abuse]], [[cocaine]], or other drugs result in [[electrolyte]] and fluid loss. Severe [[hypokalemia]] can lead to [[rhabdomyolysis]], [[prolonged QT interval]], life-threatening [[arrhythmia]], [[syncope]], and [[sudden death]].<ref name="pmid23760993">{{cite journal| author=Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R| title=QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 10 | pages= 1969-74 | pmid=23760993 | doi=10.1007/s00467-013-2517-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23760993 }} </ref><ref name="pmid17390745">{{cite journal| author=Scognamiglio R, Negut C, Calò LA| title=Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. | journal=Clin Nephrol | year= 2007 | volume= 67 | issue= 3 | pages= 193-7 | pmid=17390745 | doi=10.5414/cnp67193 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17390745 }} </ref> | *[[Hypokalemia]] in [[Bartter syndrome]] can be exacerbated by [[electrolytes]] and fluid losses. [[Diarrhea]], [[vomiting]], [[alcohol abuse]], [[cocaine]], or other drugs result in [[electrolyte]] and fluid loss. Severe [[hypokalemia]] can lead to [[rhabdomyolysis]], [[prolonged QT interval]], life-threatening [[arrhythmia]], [[syncope]], and [[sudden death]].<ref name="pmid23760993">{{cite journal| author=Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R| title=QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 10 | pages= 1969-74 | pmid=23760993 | doi=10.1007/s00467-013-2517-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23760993 }} </ref><ref name="pmid17390745">{{cite journal| author=Scognamiglio R, Negut C, Calò LA| title=Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. | journal=Clin Nephrol | year= 2007 | volume= 67 | issue= 3 | pages= 193-7 | pmid=17390745 | doi=10.5414/cnp67193 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17390745 }} </ref> | ||
*[[Glomerular filtration rate]] of <90 mL/min/1.73 m2, sometimes associated with [[proteinuria|overt proteinuria]]. | *[[Glomerular filtration rate]] of <90 mL/min/1.73 m2, sometimes associated with [[proteinuria|overt proteinuria]]. | ||
Revision as of 17:44, 4 August 2020
Main article: Bartter syndrome
|
Bartter syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bartter syndrome natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Bartter syndrome natural history, complications and prognosis |
|
FDA on Bartter syndrome natural history, complications and prognosis |
|
CDC on Bartter syndrome natural history, complications and prognosis |
|
Bartter syndrome natural history, complications and prognosis in the news |
|
Blogs on Bartter syndrome natural history, complications and prognosis |
|
Risk calculators and risk factors for Bartter syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
Natural History
- Bartter Syndrome usually occurs in childhood. Patient presents with the history of:
- Constipation
- Growth failure. The rate of weight gain is much lower than that of other children of similar age and gender.
- Increased urinary frequency. The patient needs to urinate more often than usual.
- Low blood pressure
- Nephrolithiasis (Kidney stones)
- Muscle cramping and weakness[1]
Complications
Kidney failure is a possible complication.
- Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis.[2]
- Gallstones might represent a new complication of antenatal Bartter syndrome.[3] Gallstone formation might result from an altered function of either the sodium–potassium–chloride cotransporter or the channel ROMK within the hepatobiliary system.[3]
- Hypokalemia in Bartter syndrome can be exacerbated by electrolytes and fluid losses. Diarrhea, vomiting, alcohol abuse, cocaine, or other drugs result in electrolyte and fluid loss. Severe hypokalemia can lead to rhabdomyolysis, prolonged QT interval, life-threatening arrhythmia, syncope, and sudden death.[4][5]
- Glomerular filtration rate of <90 mL/min/1.73 m2, sometimes associated with overt proteinuria.
- Prolonged hypokalemia can lead to interstitial fibrosis and tubular atrophy.[6]
Prognosis
- The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic Bartter Syndrome (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained hypokalemia and hyperreninemia can cause progressive tubulointerstitial nephritis, resulting in end-stage renal disease (Kidney failure). With the early treatment of the electrolyte imbalances, the prognosis for patients with Classic Bartter Syndrome is good.
- Patients with Bartter syndrome type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.[3]
References
- ↑ "Bartter syndrome: MedlinePlus Medical Encyclopedia".
- ↑ Seyberth HW (2008). "An improved terminology and classification of Bartter-like syndromes". Nat Clin Pract Nephrol. 4 (10): 560–7. doi:10.1038/ncpneph0912. PMID 18695706.
- ↑ 3.0 3.1 3.2 Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F; et al. (2010). "Long-term follow-up of patients with Bartter syndrome type I and II". Nephrol Dial Transplant. 25 (9): 2976–81. doi:10.1093/ndt/gfq119. PMID 20219833.
- ↑ Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R (2013). "QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study". Pediatr Nephrol. 28 (10): 1969–74. doi:10.1007/s00467-013-2517-5. PMID 23760993.
- ↑ Scognamiglio R, Negut C, Calò LA (2007). "Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes". Clin Nephrol. 67 (3): 193–7. doi:10.5414/cnp67193. PMID 17390745.
- ↑ Reungjui S, Roncal CA, Sato W, Glushakova OY, Croker BP, Suga S; et al. (2008). "Hypokalemic nephropathy is associated with impaired angiogenesis". J Am Soc Nephrol. 19 (1): 125–34. doi:10.1681/ASN.2007030261. PMC 2391040. PMID 18178802.